New data on private healthcare in the UK shows how the Covid-19 pandemic has led to an estimated 84% drop in privately funded care.
Beckman Coulter has shipped more than 16,000 SARS-CoV-2 IgG immunoassay analysers worldwide and has ramped its manufacturing to deliver more than 30 million tests a month.
A new voluntary COVID-19 study to assess and monitor the prevalence of COVID-19 among pre-school, primary and secondary school pupils and teachers has been launched by the government.
UKAS is currently assessing over 30 laboratories who have requested an extension to their scope of accreditation to include COVID-19 testing.
Healthcare staff working in some of the most high-risk COVID-19 settings are still struggling to access the protective personal equipment (PPE) they need to keep them safe.
The findings of a new Diabetes UK survey show that two thirds (67%) of people with diabetes attending work do not feel safe. More than half of respondents (54%) also say their employer is not enabling them to socially distance at work.
Amid warnings that BAME nursing staff may be disproportionately affected by the COVID-19 pandemic, an RCN survey reveals that they are more likely to struggle to secure adequate PPE while at work.
The 200,000 testing capacity target was reached on Saturday 30 May, at 205,634. The increased testing capacity has now allowed for the rollout of the new NHS Test and Trace system, which will identify and isolate new cases of the virus.
A survey by the Royal College of Anaesthetists has found that access to testing has improved, but significant concerns remain around personal protective equipment and anaesthetic drugs availability.
Local authorities will be central to supporting the new test and trace service across England, with the Government providing a new funding package of £300 million.
The Queen’s Nursing Institute has published a new document, Minimum Bridging Competencies for General Practice Nurses Transitioning to Community Nursing.
New antibody testing programme to provide tens of thousands of antibody tests per day across the UK from next week.
People living with diabetes face a significantly higher risk of dying with COVID-19 with a third of deaths in England associated with the condition, according to new NHS research. The health service in England has called on people with diabetes to access help available to them, including a new dedicated helpline and online tools to help manage the condition during the outbreak.
CliniSys has delivered a laboratory link for NHS Nightingale Hospital Bristol (Nightingale Bristol), so clinicians can request tests for patients and receive the results electronically
A new online reporting site, dedicated to reporting any suspected side effects from medicines and medical equipment, relating to COVID-19 treatment, has been launched.